William R Shepard bought $312K of CME (CME)
Executed Jan 16 2025, disclosed Jan 17 2025, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Jan 17 2025), the stock returned +6.2% (delay-adjusted); from the execution session (Jan 16 2025), +7.6%. Derived: entry at the session's open, exit at the close 20 sessions later.
William R Shepard (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in CME Group Inc. (CME). Across 1 priced purchase filing, the average 21-session return was -4.2% from execution and -4.3% from disclosure (delay-adjusted; derived). The largest single filing was $419K of CME (1,408 sh × $297.38, as filed), executed Mar 26.
Financial Services · CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts world…
More Financial Services filings→ Insider filings, newest first→ View the original filing at www.sec.gov→1,408 sh × $297.38
Exec Mar 26
Filed Mar 30 · 5:30 PM ET CMEPURCHASE CME Group Inc. $311K
1,362 sh × $227.96
Exec Jan 16 2025
Filed Mar 27 2025 · 5:30 PM ET †